← Back to patent-cliff list
盐酸乙胺丁醇/利福平/异烟肼
Tier C — Watch / tradeEthambutol Hydrochloride/Rifampicin/Isoniazid
沈阳红旗制药有限公司
Originator
2008
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：RNAP、rpoB
Brand：安思诺康
Indications (approved)：结核分枝杆菌感染
Regional status
US
-
EU
-
China
批准上市
2008-03-03
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Ethambutol Hydrochloride/Rifampicin/Isoniazid?
Approved indications include: 结核分枝杆菌感染.
When does the Ethambutol Hydrochloride/Rifampicin/Isoniazid patent expire?
No public expiry year is available for Ethambutol Hydrochloride/Rifampicin/Isoniazid yet; this page updates once verified.
How do I get a quote for Ethambutol Hydrochloride/Rifampicin/Isoniazid intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24